Mastrocola Lauren 4

Accession 0001104659-25-115098

CIK 0001689548other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 9:39 PM ET

Size

33.8 KB

Accession

0001104659-25-115098

Insider Transaction Report

Form 4

Period: 2025-11-20

Praxis Precision Medicines, Inc.PRAX

Mastrocola Lauren

Principal Accounting Officer

Transactions

Exercise/Conversion
Common Stock
2025-11-20$43.37/sh+2,680$116,232→ 16,233.656 total
Exercise/Conversion
Common Stock
2025-11-20$44.40/sh+207$9,191→ 16,440.656 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−1,557→ 0 total
Exercise: $133.65Exp: 2030-09-13→ Common Stock (1,557 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−207→ 0 total
Exercise: $44.40From: 2023-01-12Exp: 2033-01-12→ Common Stock (207 underlying)
Exercise/Conversion
Common Stock
2025-11-20$83.85/sh+508$42,596→ 11,996.656 total
Sale
Common Stock
2025-11-20$191.96/sh−11,455$2,198,879→ 12,586.656 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−1,047→ 0 total
Exercise: $49.50Exp: 2029-09-23→ Common Stock (1,047 underlying)
Exercise/Conversion
Common Stock
2025-11-20$49.50/sh+1,047$51,827→ 11,488.656 total
Exercise/Conversion
Common Stock
2025-11-20$133.65/sh+1,557$208,093→ 13,553.656 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−508→ 0 total
Exercise: $83.85Exp: 2030-06-04→ Common Stock (508 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−5,250→ 11,376 total
Exercise: $56.94Exp: 2034-07-29→ Common Stock (5,250 underlying)
Exercise/Conversion
Common Stock
2025-11-20$44.40/sh+2,351$104,384→ 18,791.656 total
Exercise/Conversion
Common Stock
2025-11-20$56.94/sh+5,250$298,935→ 24,041.656 total
Sale
Common Stock
2025-11-20$192.71/sh−2,145$413,365→ 10,441.656 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−2,680→ 9,320 total
Exercise: $43.37Exp: 2034-01-12→ Common Stock (2,680 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−2,351→ 981 total
Exercise: $44.40Exp: 2033-01-12→ Common Stock (2,351 underlying)

Footnotes (8)

[F1]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $191.500 to $192.432. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
[F2]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $192.552 to $193.109. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
[F3]This option was fully vested as of January 1, 2023.
[F4]This option was fully vested as of May 28, 2024.
[F5]This option was fully vested as of September 8, 2024.
[F6]The shares underlying this stock option vested as to 50% on January 12, 2024 and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on January 12, 2025 and the remaining vesting in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date.
[F7]The shares underlying this stock option vested as to 25% on January 12, 2024 and the remaining shares vest in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date.
[F8]The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the Reporting Person's continued service through each vesting date.

Documents

1 file

4
tm2531977-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Praxis Precision Medicines, Inc.

CIK 0001689548

→

Entity typeother

Related Parties

filerCIK 0001827639

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 9:39 PM ET
Size: 33.8 KB

View on SEC.gov